Real-world results of a new balloon-in-basket pulsed field ablation catheter for atrial fibrillation
Part of Heart & circulation clinical trials.
This study tracks patients who have atrial fibrillation and receive a new type of ablation therapy using a special balloon that delivers short electrical pulses. It aims to see how well this new device works in everyday medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are scheduled to have a catheter ablation for atrial fibrillation using a specific new device called VOLT PFA.
- You are willing and able to give written permission to be in the study.
- You do not have a left atrium larger than 60 mm.
- You do not have severe problems with your mitral valve or a past valve surgery.
- You do not have a blood clot in your heart or a condition that prevents safe use of blood thinners.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new balloon catheter that uses pulsed electric fields to isolate the veins that carry blood from your lungs to your heart. It may be a treatment option for people with atrial fibrillation who are scheduled for an ablation procedure.
This trial tests a balloon catheter that uses pulsed field energy to treat atrial fibrillation (AF) in people who have tried medication without success. It aims to see how well it works in real-world use.
This trial tests a new balloon device that uses gentle energy pulses to treat atrial fibrillation (AF), a type of irregular heartbeat. It may help people whose AF has not improved with medication.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
Hear when a new Treatment of Atrial Fibrilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.